DUBLIN, Calif., Sept. 21 /PRNewswire-FirstCall/ -- SuperGen Inc. today announced that James S. Manuso, Ph.D., President and Chief Executive Officer is scheduled to present at the UBS Global Life Sciences Conference, at 8:00 a.m. EDT on Sept. 28, 2006, at the Grand Hyatt Hotel in New York City. Dr. Manuso will provide a brief corporate overview and discuss the Company's recent progress.
A live Webcast of Dr. Manuso's presentation will be available on the Investor Relations section of the Company's website at www.supergen.com. The Webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen is a pharmaceutical company dedicated to the discovery, acquisition, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on inhibitors of aurora-A, tyrosine kinase and DNA methyltransferase. For more information about SuperGen, please visit http://www.supergen.com.
Contacts: SuperGen Timothy L. Enns S.V.P., Corporate Communications & Business Development (925) 560-0100 x111 tenns@supergen.com Noonan Russo Sharon Weinstein, (212) 845-4271 (Investors) sharon.weinstein@eurorscg.com Tracey Milani, (858) 546-4811 (Media) tracey.milani@eurorscg.com
SuperGen Inc.CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & BusinessDevelopment of SuperGen, +1-925-560-0100 x111, tenns@supergen.com; orInvestors, Sharon Weinstein, +1-212-845-4271,sharon.weinstein@eurorscg.com, or Media, Tracey Milani, +1-858-546-4811,tracey.milani@eurorscg.com, both of Noonan Russo, for SuperGen Inc.
Web site: http://www.supergen.com/
